¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
 ÃÖ¿ì¼ö³í¹®»ó
2013³â 1¿ùºÎÅÍ 12¿ù±îÁö ´ëÇÑ»êºÎÀΰúÇÐȸÁö OGS(Obstetrics & Gynecology Science)¿¡ °ÔÀçµÈ ³í¹®À» ´ë»óÀ¸·Î
¾öÁ¤ÇÑ ½É»ç¸¦ ÅëÇØ ¼±Á¤µÈ ÃÖ¿ì¼ö/¿ì¼ö ³í¹®ÀÇ Á¦1ÀúÀÚ ¶Ç´Â ±³½ÅÀúÀÚ¿¡°Ô ÁÖ¾îÁö´Â »óÀÔ´Ï´Ù.

2014³âµµ Á¦ 100Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ ÃÖ¿ì¼ö³í¹®»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.
¸ðüžÆÀÇÇÐ
ÃÖ¿ì¼ö³í¹®»ó
  • ¼º¸í : ±èÁö¿¬
  • ¼Ò¼Ó : °í·ÁÀÇ´ë
  • ³í¹®Á¦¸ñ : Three-dimensional volumetric gray-scale uterine cervix histogram prediction of days to delivery in full term
                   pregnancy
  • °ÔÀç±ÇÈ£ : OGS.2014.56.5.312
¿ì¼ö³í¹®»ó
  • ¼º¸í : ±ÇÀÚ¿µ
  • ¼Ò¼Ó : ¿¬¼¼ÀÇ´ë
  • ³í¹®Á¦¸ñ : Random urine protein/creatinine ratio readily predicts proteinuria in preeclampsia.
  • °ÔÀç±ÇÈ£ : OGS.2014.56.1.8
  • ¼º¸í : ÀüÁ¾°ü
  • ¼Ò¼Ó : ¼­¿ïÀÇ´ë
  • ³í¹®Á¦¸ñ : Simplified protocol of nuchal translucency measurement: is it still effective?
  • °ÔÀç±ÇÈ£ : OGS.2014.56.5.307
ºÎÀÎÁ¾¾çÇÐ
ÃÖ¿ì¼ö³í¹®»ó
  • ¼º¸í : À̱ÙÈ£
  • ¼Ò¼Ó : °¡Å縯ÀÇ´ë
  • ³í¹®Á¦¸ñ : Regulation of paclitaxel-induced programmed cell death by autophagic induction: A model for cervical cancer.
  • °ÔÀç±ÇÈ£ : OGS.2014.56.2.84
¿ì¼ö³í¹®»ó
  • ¼º¸í : ±è½Âö
  • ¼Ò¼Ó : ÀÌÈ­ÀÇ´ë
  • ³í¹®Á¦¸ñ : Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study
  • °ÔÀç±ÇÈ£ : OGS.2014.56.4.234
  • ¼º¸í : ±è¹ÎÁ¤
  • ¼Ò¼Ó : ¼­¿ïÀÇ´ë
  • ³í¹®Á¦¸ñ : Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health
                   check-ups of 7,014 Korean women.
  • °ÔÀç±ÇÈ£ : OGS.2014.56.2.110
»ý½Ä³»ºÐºñÇÐ
ÃÖ¿ì¼ö³í¹®»ó
  • ¼º¸í : ±¸À±Èñ
  • ¼Ò¼Ó : ºÎ»êÀÇ´ë
  • ³í¹®Á¦¸ñ : Expression of CD44 in endometrial stromal cells from women with and without endometriosis and its effect on
                   the adherence to peritoneal mesothelial cells.
  • °ÔÀç±ÇÈ£ : OGS.2014.56.2.102
¿ì¼ö³í¹®»ó
  • ¼º¸í : À̱âȯ
  • ¼Ò¼Ó : Ãæ³²ÀÇ´ë
  • ³í¹®Á¦¸ñ : The influence of serum substituents on serum-free Vero cell conditioned culture media manufactured from
                   Dulbecco¡¯s modified Eagle medium in mouse embryo culture
  • °ÔÀç±ÇÈ£ : OGS.2014.56.5.320
  • ¼º¸í : ÃÖ¿øÁØ
  • ¼Ò¼Ó : °æ»óÀÇ´ë
  • ³í¹®Á¦¸ñ : Influence of the vitrification solution on the angiogenic factors in vitrificated mouse ovarian tissue
  • °ÔÀç±ÇÈ£ : OGS.2014.56.6.382
ÀϹݺÎÀΰúÇÐ
ÃÖ¿ì¼ö³í¹®»ó
  • ¼º¸í : ±è¿ë¹ü
  • ¼Ò¼Ó : ¼­¿ïÀÇ´ë
  • ³í¹®Á¦¸ñ : Effect of myoma size on failure of thermal balloon ablation or levonorgestrel releasing intrauterine system
                   treatment in women with menorrhagia.
  • °ÔÀç±ÇÈ£ : OGS.2014.56.1.36
¿ì¼ö³í¹®»ó
  • ¼º¸í : Á¤´ÙÀº
  • ¼Ò¼Ó : ¿¬¼¼¿øÁÖÀÇ´ë
  • ³í¹®Á¦¸ñ : The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative
                   surgical site pain compared to intravenous patient-controlled analgesia.
  • °ÔÀç±ÇÈ£ : OGS.2014.56.2.93